Company: CORT
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048841
Chunk: 95

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 8
Chunk 95
---
 cashless option exercise, of which 30,862 shares were surrendered to us in satisfaction of related exercise cost and tax obligations. In August 2025, we issued 206,422 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 91,018 shares were surrendered to us. In September 2025, we issued 31,083 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 14,037 shares were surrendered to us.

In July 2025, we issued 33,892 shares of common stock as part of restricted stock vesting, of which 12,126 shares were surrendered to us in satisfaction of related tax obligations. In August 2025, we issued 80,537 shares of common stock as part of restricted stock vesting, of which 28,515 shares were surrendered to us. In September 2025, we issued 51,012 shares of common stock as part of restricted stock vesting, of which 17,387 shares were surrendered to us.

(2) We paid $8.2 million to satisfy the tax withholding obligations associated with the net-share settlement of these cashless option exercises and vesting of restricted stock.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.

42

ITEM 5.  OTHER INFORMATION

Insider Trading Arrangements

During the three months ended September 30, 2025, no directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, terminated, or modified any contract, instruction or written plan for the purchase or sales of our securities intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange or any “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K.

43

ITEM 6.  EXHIBITSExhibitNumber Description of Document3.1 Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed on May 24, 2023).3.2 Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form